Enorama Pharma
2.47
SEK
-16.55 %
Less than 1K followers
ERMA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-16.55%
+10.76%
-17.11%
-26.49%
-35.68%
-13.33%
-86.39%
-92.04%
-61.21%
Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are mainly sold through retailers who sell the product under their own brand. The largest market is established in the Nordic region, but also worldwide. Enorama Pharma was founded in 2006 and the head office is located in Malmö.
Read moreMarket cap
165.83M SEK
Turnover
3.57K SEK
Revenue
15.77M
EBIT %
-301.33 %
P/E
-
Dividend yield-%
-
Financial calendar
21/5
2025
Interim report Q1'25
20/8
2025
Interim report Q2'25
19/11
2025
Interim report Q3'25
All
Press releases
ShowingAll content types
Enorama Pharma: ENORAMA PHARMA: KOMMUNIKÉ FRÅN ÅRSSTÄMMAN I ENORAMA PHARMA AB (PUBL)
Enorama Pharma AB (publ) offentliggör årsredovisning och revisionsberättelse
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools